Rivus Pharmaceuticals
- Headquarters
- Charlottesville
- Employees
- 11–50
- Business Model
- B2B
- Website
- rivuspharma.com
About
Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of cardio-metabolic disease. Its first-in-class small molecule therapy, HU6, is a Controlled Metabolic Accelerator (CMA) that activates mitochondrial uncoupling to address the underlying cause of conditions including type 2 diabetes, hypertension, NASH, and obesity. The company has advanced HU6 through multiple Phase 2 clinical trials and is backed by investors including Medicxi, Longitude Capital, RA Capital Management, and Bain Capital Life Sciences.
Summary
Rivus Pharmaceuticals is a Biotech company based in Charlottesville, United States.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company